Figure 12From: Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapyOverall survival according to 52 NSCLC patients who have both ERCC1 and BAG-1 expression, all of whom were based on platinum chemotherapy (more than 42.6 vs. 17.0 months, P = 0.000).Back to article page